The objectives of INDUCT are to: determine practical, cognitive & social factors to improve usability of technology; evaluate the effectiveness of specific contemporary technology; trace facilitators & barriers for implementation of technology in dementia care. Using advanced methods in applied health research (e.g. randomised controlled trials, qualitative studies) INDUCT will provide the evidence needed to demonstrate how to make dementia care technology more usable, more effective, and better implemented in practice, culminating in an international consensus guideline for improving policy and practice.
The unique academic and non-academic collaborative partnership of INDUCT comprises of 13 world leading research organisations across 8 European countries, 9 partners who include Alzheimer Europe, Alzheimer Disease International, the World Federation of Occupational Therapists and 3 SMEs for technology and dementia care. Many members of the DISTINCT team are the established researchers in the INTERDEM, an interdisciplinary European collaborative research network of 180 leading academics working to improve early detection and timely and quality psychosocial interventions in dementia.
IDES will have 1 Early Stage Researchers (ESRs), ESR15. Each of ESR will belong to one of the INDUCT research organisations where their primary supervisors are based.
Project Title and Work Package(s) to which it is related: WP5 Evaluation of GRADIOR a cognitive rehabilitation application for dementia.
Objectives: ESR15 will develop a clinical trial comparing GRADIOR to usual care in people with mild dementia. ESR 15 will also translate, adapt and trial GRADIOR in the Netherlands. The GRADIOR software developed by the IDES is used in over 450 centres at national and international level within the social and health sector. It can remotely assess neuropsychology problems and allow the professional to tailor the interventions to the specific cognitive difficulties of the person with dementia. Within a rehabilitation program it is designed to train attention, perception, language, reasoning and memory. However, the effectiveness of GRADIOR has not been evaluated in depth.
Expected Results: The results will provide an evaluation of GRADIOR as an application suitable for remote evaluation and rehabilitation of cognitive problems. It will also (in collaboration with ESR9 and ESR10) provide a translation & second evaluation of GRADIOR providing evidence about how adaptable and transferable it is to other languages and settings.
Planned secondment(s): Two secondments of 3 months each. Firstly to UoN in year one to learn about complex intervention and trial methodology. Secondly to MU-NL to adapt GRADIOR to the Dutch population and develop a better understanding of cross cultural issues.
Contact: Prof Manuel Franco Martín (email@example.com)
Project: Horizon 2020
Call: H2020-MSCA-ITN-2015 (Marie Skłodowska-Curie Innovative Training Networks)
GRANT AGREEMENT: NUMBER 676265
DURATION AND STARTING DATE OF THE ACTION: The duration of the action will be 48 months as of 1 March 2016 (‘starting date of the action’).
The estimated eligible costs of the action are EUR 3 878 757 (three million eight hundred and seventy eight thousand seven hundred and fifty seven euros)